Literature DB >> 17450378

Pulmonary vascular changes in piglets with increased pulmonary blood flow and pressure.

Matthias Gorenflo1, Esther Herpel, Michael V Ullmann, Karoline Röhlig, Sueha Demirakca, Homa Klimpel, Siegfried Hagl, Martha Maria Gebhard, Philipp A Schnabel.   

Abstract

In this model of pulmonary vascular disease, high pulmonary blood flow was created by an anastomosis between the left subclavian artery and the main pulmonary artery [Blalock-Taussig (BT) shunt] in 4-week-old piglets (n = 6). Additional ligation of the left pulmonary artery (LPA) was used to increase pulmonary artery pressure (n = 6). Seven piglets were sham-operated. After 3 months, mean pulmonary artery pressure was higher in animals with BT shunt and LPA ligation (22 +/- 5; mean+/-SD) compared to sham-operated animals (15 +/- 2). In addition, thickening of the medial coat (20.1 +/- 2.8% versus 13.6 +/- 3.1% wall thickness) and increased immunostaining for vascular endothelial growth factor A (VEGF-A) were observed. Relative gene expression for endothelin-converting enzyme-1 (ECE-1) mRNA was 1.8 times higher, and VEGF-A mRNA was 2.5 times higher in pigs with BT shunt and LPA ligation compared with sham-operated animals. VEGF receptor-1 and VEGF receptor-2 mRNA was lower in shunted animals and in animals with additional ligation of LPA. Upregulation of ECE-1 and VEGF-A, as well as changes in VEGFR expression in the pulmonary hypertensive lung, may contribute to pulmonary vascular changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450378     DOI: 10.1007/s00428-007-0414-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  eNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flow.

Authors:  A D Everett; T D Le Cras; C Xue; R A Johns
Journal:  Am J Physiol       Date:  1998-06

3.  Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.

Authors:  Benoît Rondelet; François Kerbaul; Sophie Motte; Ronald van Beneden; Myriam Remmelink; Serge Brimioulle; Kathleen McEntee; Pierre Wauthy; Isabelle Salmon; Jean-Marie Ketelslegers; Robert Naeije
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Plasma L-arginine and metabolites of nitric oxide synthase in patients with left-to-right shunt after intracardiac repair.

Authors:  Matthias Gorenflo; Michael V Ullmann; Katharina Eitel; Jasmin Gross; Walter Fiehn; Siegfried Hagl; Jens Dreyhaupt
Journal:  Chest       Date:  2005-04       Impact factor: 9.410

5.  Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.

Authors:  Eugenia Mata-Greenwood; Barbara Meyrick; Scott J Soifer; Jeffrey R Fineman; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-03-28       Impact factor: 5.464

6.  Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer.

Authors:  Paul-Eduard Neagoe; Caroline Lemieux; Martin G Sirois
Journal:  J Biol Chem       Date:  2005-01-06       Impact factor: 5.157

Review 7.  Vascular endothelial growth factor in the lung.

Authors:  Norbert F Voelkel; R William Vandivier; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-02       Impact factor: 5.464

8.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

9.  The index of pulmonary vascular disease in children with congenital heart disease: relationship to clinical and haemodynamic findings.

Authors:  M Gorenflo; M Ullmann; C Sebening; K Brockmeier; S Hagl; H E Ulmer; H F Otto; P A Schnabel
Journal:  Virchows Arch       Date:  2002-05-30       Impact factor: 4.064

10.  Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics.

Authors:  D S Celermajer; S Cullen; J E Deanfield
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.